Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: Implications for treatment guidelines

Acta Dermato-Venereologica

Volumn 89, Issue 5, 2009, Pages 484-487

  Farhi, David ^a   Hotz, Claire ^a   Poupet, Hélène ^b   Gerhardt, Philippe ^a   Morand, Philippe ^b   Poyart, Claire ^b   Sednaoui, Patrice ^c   Avril, Marie Françoise ^a   Dupin, Nicolas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Alfred Fournier ^*  (France)

^c INSTITUT ALFRED FOURNIER   (France)

Author keywords

Antibiotic resistance; Ciprofloxacin; HIV; Men having sex with men; Neisseria gonorrhoeae; Quinolones; Urethritis

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; FEMALE; FRANCE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SEX RATIO; SEXUAL ORIENTATION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PARIS; PENICILLIN G; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SPECTINOMYCIN; TETRACYCLINE; TIME FACTORS; YOUNG ADULT;

EID: 70350136443     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0704     Document Type: Article

References (20)

1. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007; 44 Suppl 3:S84-S101.
2. Farhi D, Aynaud O, Dupin N. Ecoulement urétral chez l'homme. Pelv Perineol 2008; 3: 1-7.
3. Tapsall JW, Shultz TR, Lovett R, Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust 1992; 156: 143.
4. Birley H, McDonald P, Carey P, Fletcher J. High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med 1994; 70: 292-293. (Pubitemid 24252946)
5. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995. MMWR Morb Mortal Wkly Rep 1995; 44: 761-764.
6. Afssaps. Mise au point. Le traitement antibiotique probabiliste des urétrites et cervicites non compliquées, [cited 2008 June 21]. Available from: URL: http://www.afssaps. sante.gouv.fr/pdf/10/mpl40905.pdf
7. Update to CDCs sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56: 332-336.
8. Farhi D, Gerhardt P, Falissard B, Poupet H, Poyart C, Dupin N. Increasing rates of quinolone-resistant Neisseria gonorrhoeae in Paris, France. J Eur Acad Dermatol Venereol 2007; 21: 818-821. (Pubitemid 46939057)
9. Su X, Jiang F, Qimuge, Dai X, Sun H, Ye S. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis 2007; 34: 995-999.
10. Tapsall JW, Limnios EA, Murphy D. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997-2006. J Antimicrob Chemother 2008; 61: 150-155.
11. Ison CA, Woodford PJ, Madders H, Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother 1998; 42: 2919-2922. (Pubitemid 28501226)
12. EUCAST, inventor Clinical breackpoints. [cited 2008 Jun 25]. Available from: URL: http://www.srga.org/eucastwt/ MICTAB/index.html. 2008
13. Soussy CJ. Communiqué 2008 du Comité de l'Antibiogramme de la Société Française de Microbiologie (CASFM). Online Pub Jan 2008. [cited 2008 June 25]. Available from: URL: http://www.sfm.asso.fr/ publi/general.php?pa=1. 2008
14. INVS. Réseau RENAGO. [Epidemiology of sexually transmitted infections in France]. [cited 2008 April 19]. Available from: URL: http://www.invs.sante.fr/publications/2007/ actualites-vih-sida-ist-2007/2- IST%20nov%202007. pdf. 2007
15. INVS. Réseau RENAGO. [Characteristics of Neisseira gonorrhoeae resistance to antibiotics]. [cited 2008 April 19]. Available from: URL: http://www.invs.sante.fr/surveillance/resistance/fiche-neisseria-gonorrhoeae. htm. 2007
16. GRASP. The Gonococcal Resistance to Antimicrobials Surveillance Programme. Annual Report 2006. [cited 2008 April 19]. Available from: URL: http://www.hpa.org.uk/ webc/HPAwebFile/HPAweb-C/1194947393147
17. Enders M, Turnwald-Maschler A, Regnath T. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. Eur J Clin Microbiol Infect Dis 2006; 25: 318-322. (Pubitemid 43829335)
18. Uthman A, Heller-Vitouch C, Stary A, Bilina A, Kuchinka- Koch A, Soltz-Szots J, et al. High-frequency of quinolone- resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes. Sex Transm Dis 2004; 31: 616-618. (Pubitemid 39281835)
19. Gonococcal Isolate Surveillance Project (GISP). Annual Report 2005. [cited 2008 April 19]. Available from: URL: http://www.cdc.gov/std/Gisp2005/ GISPSurvSupp2005short.pdf. 2007
20. Rice RJ, Knapp JS. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes. Antimicrob Agents Chemother 1994; 38: 155-158.